PTBP1 Targets ILK to Regulate the Hypoxia-Induced Phenotypic Transformation of Pulmonary Artery Smooth Muscle Cells

References

• ZhaoL, MasonNA, MorrellNW, et al. Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation. 2001;104(4):424–428. doi:10.1161/hc2901.09311711468204
   PubMed Web of Science ®Google Scholar
• OlschewskiH, SimonneauG, GalièN, et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med. 2002;11(6):19.
   Google Scholar
• Walsh-SukysMC, TysonJE, WrightLL, BauerCR. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics. 2000;105(1 Pt 1):14–20. doi:10.1542/peds.105.1.1410617698
   PubMed Web of Science ®Google Scholar
• OlschewskiH, GhofraniHA, WalmrathD, et al. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. Am J Respir Crit Care Med. 1999;160(2):600–607. doi:10.1164/ajrccm.160.2.981000810430735
   PubMed Web of Science ®Google Scholar
• KornblihttAR, SchorIE, AllóM, DujardinG, PetrilloE, MuñozMJ. Alternative splicing: a pivotal step between eukaryotic transcription and translation. Nat Rev Mol Cell Biol. 2013;14(3):153–165. doi:10.1038/nrm352523385723
   PubMed Web of Science ®Google Scholar
• ChristofkHR, Vander HeidenMG, HarrisMH, et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature. 2008;452(7184):230–233. doi:10.1038/nature0673418337823
   PubMed Web of Science ®Google Scholar
• HanniganGE, LeunghagesteijnC, FitzgibbonL, et al. Regulation of cell adhesion and anchorage-dependent growth by a new |[beta]|1-integrin-linked protein kinase. Nature. 1996;379(6560):91–96. doi:10.1038/379091a08538749
   PubMed Web of Science ®Google Scholar
• JieW, GuoJ, ShenZ, et al. Contribution of myocardin in the hypoxia-induced phenotypic switching of rat pulmonary arterial smooth muscle cells. Exp Mol Pathol. 2010;89(3):301–306. doi:10.1016/j.yexmp.2010.06.01020621093
   PubMed Web of Science ®Google Scholar
• ChettimadaS, GupteR, RawatD, GebbSA, GupteSA, PhysiologyM. Hypoxia-induced glucose-6-phosphate dehydrogenase overexpression and activation in pulmonary artery smooth muscle cells: implication in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2014;308(3):ajplung.00229.02014. doi:10.1152/ajplung.00229.2014
   Web of Science ®Google Scholar
• MengJ, AiX, LeiY, et al. USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma. Theranostics. 2019;9(2):573–587. doi:10.7150/thno.2765430809294
   PubMed Web of Science ®Google Scholar
• XiX, LiuN, WangQ, et al. ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K/AKT pathway in glioma. Cell Death Dis Oct. 2019;10(10):757. doi:10.1038/s41419-019-1986-2
   PubMed Web of Science ®Google Scholar
• ZhongW, YangW, QinY, et al. 6-Gingerol stabilized the p-VEGFR2/VE-cadherin/beta-catenin/actin complex promotes microvessel normalization and suppresses tumor progression. J Exp Clin Cancer Res. 2019;38(1):285. doi:10.1186/s13046-019-1291-z31266540
   PubMed Web of Science ®Google Scholar
• ZhongW, SunB, GaoW, et al. Salvianolic acid A targeting the transgelin-actin complex to enhance vasoconstriction. E Bio Med. 2018;37:246–258. doi:10.1016/j.ebiom.2018.10.041
   Web of Science ®Google Scholar
• RichS, DantzkerDR, AyresSM, BergofskyEH, KoernerSK. Primary pulmonary hypertension: a national prospective study. Ann Intern Med. 1987;107(2):216–223. doi:10.7326/0003-4819-107-2-2163605900
   PubMed Web of Science ®Google Scholar
• ParkYM, ChungWJ, LeeSP, et al. Efficacy of inhaled iloprost in cor pulmonale and severe pulmonary hypertension associated with tuberculous destroyed lung. J Cardiovasc Ultrasound. 2014;22(2):95–97. doi:10.4250/jcu.2014.22.2.9525031802
   PubMedGoogle Scholar
• McLaughlinVV, ShillingtonA, RichS. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation. 2002;106(12):1477–1482. doi:10.1161/01.CIR.0000029100.82385.5812234951
   PubMed Web of Science ®Google Scholar
• HerbayAV, IllesA, WaldherrR, OttoHF. Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer. 1990;66(3):587–592. doi:10.1002/1097-0142(19900801)66:3<587::AID-CNCR2820660330>3.0.CO;2-J2163747
   PubMed Web of Science ®Google Scholar
• GalièN, HoeperMM, HumbertM, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the Internati. Eur Heart J. 2015;37(1):67–119. doi:10.1093/eurheartj/ehv31726320113
   PubMed Web of Science ®Google Scholar
• D’AlonzoGE, BarstRJ, AyresSM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med. 1991;115(5):343–349. doi:10.7326/0003-4819-115-5-3431863023
   PubMed Web of Science ®Google Scholar
• FishmanAP. Clinical classification of pulmonary hypertension. Clin Chest Med. 2001;22(3):385–391. doi:10.1016/S0272-5231(05)70278-111590835
   PubMed Web of Science ®Google Scholar
• AbeK, ShimokawaH, MorikawaK, et al. Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circ Res. 2004;94(3):385–393. doi:10.1161/01.RES.0000111804.34509.9414670839
   PubMed Web of Science ®Google Scholar
• BaberSR, DengW, MasterRG, et al. Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2007;292(2):H1120–H1128. doi:10.1152/ajpheart.00173.200616980338
   PubMed Web of Science ®Google Scholar
• RosenbergHC, RabinovitchM. Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension. Am J Physiol. 1988;255(6 Pt 2):H1484–H1491. doi:10.1152/ajpheart.1988.255.6.H14843144186
   PubMed Web of Science ®Google Scholar
• CobboldLC, WilsonLA, SawickaK, et al. Upregulated c-myc expression in multiple myeloma by internal ribosome entry results from increased interactions with and expression of PTB-1 and YB-1. Oncogene. 2010;29(19):2884–2891. doi:10.1038/onc.2010.3120190818
   PubMed Web of Science ®Google Scholar
• ShenD, LiJ, LeporeJJ, AndersonT. Aortic aneurysm generation in mice with targeted deletion of integrin-linked kinase in vascular smooth muscle cells. Circ Res. 2011;109(6):616–628. doi:10.1161/CIRCRESAHA.110.23934321778429
   PubMed Web of Science ®Google Scholar